The pharma services space is abuzz with activity as funding rebounds, R&D activity grows and technology accelerates innovation. Clinical trial site management organizations (CTSMOs), contract research organizations (CROs) and research technology vendors play a key role in the conduct, acceleration and digitization of clinical research in the life sciences industry. By deploying innovative methods in subject recruitment and using tech-enabled solutions to create more efficient, scalable and sophisticated platforms for the conduct and oversight of clinical research, they present myriad opportunities for investors to add value and expand their portfolios. However, this highly regulated space requires specialized due diligence to ensure success.
Read the full article: Investing in Clinical Trial Site Management Organizations: Key Regulatory and Diligence Considerations //
Source: https://www.lexology.com/library/detail.aspx?g=16b96b79-d850-43a2-97a0-202190f0ecc3